Epstein Secrets

he Office of Congressional Ethics reported that it found "a substantial reason to believe" that Collins violated federal law by touting the stock of Innate Immunotherapeutics, an Australian biotech firm, based on inside information. The office also said Collins may have broken House ethics rules by persuading National In

charges were brought against Rochester Drug Co-operative. Geoffrey S. Berman, the United States Attorney for the Southern District of New York, and Ray Donovan, the Special Agent in Charge of the New York Division of the U.S. Drug Enforcement Administration (DEA), announced the charges. Rochester Drug Co-O

he Office of Congressional Ethics reported that it found "a substantial reason to believe" that Collins violated federal law by touting the stock of Innate Immunotherapeutics, an Australian biotech firm, based on inside information. The office also said Collins may have broken House ethics rules by persuading National In

charges were brought against Rochester Drug Co-operative. Geoffrey S. Berman, the United States Attorney for the Southern District of New York, and Ray Donovan, the Special Agent in Charge of the New York Division of the U.S. Drug Enforcement Administration (DEA), announced the charges. Rochester Drug Co-O

he Office of Congressional Ethics reported that it found "a substantial reason to believe" that Collins violated federal law by touting the stock of Innate Immunotherapeutics, an Australian biotech firm, based on inside information. EFTA00085695 The office also said Collins may have broken House ethics rules by persuad

charges were brought against Rochester Drug Co-operative. Geoffrey S. Berman, the United States Attorney for the Southern District of New York, and Ray Donovan, the Special Agent in Charge of the New York Division of the U.S. Drug Enforcement Administration (DEA), announced the charges. Rochester Drug Co-O

he Office of Congressional Ethics reported that it found "a substantial reason to believe" that Collins violated federal law by touting the stock of Innate Immunotherapeutics, an Australian biotech firm, based on inside information. The office also said Collins may have broken House ethics rules by persuading National In

charges were brought against Rochester Drug Co-operative. Geoffrey S. Berman, the United States Attorney for the Southern District of New York, and Ray Donovan, the Special Agent in Charge of the New York Division of the U.S. Drug Enforcement Administration (DEA), announced the charges. Rochester Drug Co-O

he Office of Congressional Ethics reported that it found "a substantial reason to believe" that Collins violated federal law by touting the stock of Innate Immunotherapeutics, an Australian biotech firm, based on inside information. The office also said Collins may have broken House ethics rules by persuading National In

charges were brought against Rochester Drug Co-operative. Geoffrey S. Berman, the United States Attorney for the Southern District of New York, and Ray Donovan, the Special Agent in Charge of the New York Division of the U.S. Drug Enforcement Administration (DEA), announced the charges. Rochester Drug Co-O